期刊文献+

沙立芦单抗对类风湿关节炎滑膜细胞增殖和凋亡的影响 被引量:1

Effect and Mechanism of Sarilumab on Proliferation and Apoptosis of Rheumatoid Arthritis Synoviocytes
下载PDF
导出
摘要 [目的]探讨沙立芦单抗对类风湿性关节炎(RA)滑膜细胞增殖、凋亡的影响.[方法]体外培养人RA细胞系FLS细胞(RA-FLS细胞),随机分为空白对照组和沙立芦单抗低剂量组(加入2.5 mg/L沙立芦单抗溶液)、中剂量组(加入5.0 mg/L沙立芦单抗溶液)、高剂量组(加入10.0 mg/L沙立芦单抗溶液).采用CKK-8法检测各组RA-FLS细胞增殖抑制率;采用AnnexinV-FITC/PI双染法检测各组RA-FLS细胞凋亡率;采用蛋白免疫印迹法检测各组细胞兔抗细胞增殖相关核抗原(PCNA)、凋亡蛋白B淋巴细胞瘤-2(Bcl-2)、Bcl-2相关X蛋白(Bax)及蛋白酪氨酸激酶Janus激酶1/转录活化蛋白3(JAK1/STAT3)通路蛋白(JAK1、p-JAK1、STAT3、p-STAT1蛋白)表达水平.[结果]与空白对照组相比,沙立芦单抗低剂量组、中剂量组、高剂量组RA-FLS细胞增殖抑制率升高(P<0.05),且呈剂量依赖性(P<0.05);与空白对照组相比,沙立芦单抗低剂量组、中剂量组、高剂量组RA-FLS细胞凋亡率升高(P<0.05),且呈剂量依赖性(P<0.05);与空白对照组比较,沙立芦单抗低剂量组、中剂量组、高剂量组RA-FLS细胞PCNA、Bcl-2蛋白降低(P<0.05),Bax蛋白升高(P<0.05),且呈剂量依赖性(P<0.05);与空白对照组比较,沙立芦单抗低剂量组、中剂量组、高剂量组RA-FLS细胞IL-6、p-JAK1/JAK1、p-STAT3/STAT3蛋白升高(均P<0.05),且呈剂量依赖性.[结论]沙立芦单抗可能通过抑制IL-6/JAK1/STAT3通路活化进而抑制RA-FLS细胞增殖,并诱导细胞凋亡,可为临床治疗RA提供一定参考. 【Objective】To investigate the effects of sarilumab on the proliferation and apoptosis of rheumatoid arthritis(RA)cells,and to analyze the related mechanisms.【Methods】Human RA cell line FLS cells(RA-FLS cells)were cultured in vitro and divided into the control group,the sarilumab low,medium and high dose groups(final concentration of 2.5 mg/L,5.0 mg/L and 10.0 mg/L,respectively).The proliferation inhibition rate of RA-FLS cells was detected by CKK-8 and the apoptosis rate of RA-FLS cells was detected by Annexin V-FITC/PI double staining.The expression of anti-proliferation related nuclear Antigen(PCNA),apoptosis protein B lymphocyte-2(Bcl-2),Bcl-2 related X protein(Bax)and protein tyrosine kinase of Janus kinase 1/STAT3 pathway protein(JAK1,p-JAK1,STAT3 and p-STAT1)was detected by Western blotting.【Results】The proliferation inhibition rate,apoptosis rate and expression levels of PCNA and Bcl-2 protein in RA-FLS cells from the sarilumab low,middle and high dose groups were higher than those in the control group(P<0.05),while the levels of Bax and p-JAK1/JAK1,p-STAT3/STAT3 were significantly lower than those in the control group(P<0.05).All of those dectections were in dose dependent manner(P<0.05).【Conclusion】Sarilumab may inhibit the proliferation of RA-FLS cells and induce apoptosis by inhibiting the activation of IL-6/JAK1/STAT3 pathway.
作者 王潇 王桂玲 刘彤 WANG Xiao;WANG Gui-ling;LIU Tong(Department of Spinal Cord Surgery,The Third Hospital of Shandong Province,Jinan Shandong 250031)
出处 《医学临床研究》 CAS 2023年第1期102-104,共3页 Journal of Clinical Research
关键词 关节炎 类风湿 抗体 单克隆 滑膜细胞 细胞增殖 细胞凋亡 Arthritis,Rheumatoid Antibodies,Monoclonal Synoviocytes Cell Proliferation Apoptosis
  • 相关文献

参考文献11

二级参考文献58

  • 1李春英,梁爱华,高双荣,回连强,刘婷,曹春雨,赵雍,郝然,易艳,郭静.大鼠胃癌前病变模型的建立[J].中国中药杂志,2012,37(1):89-93. 被引量:19
  • 2Ravelli A, Martini A. Juvenile idiopathic arthritis[J]. Lancet, 2007, 369(9563):767-778. 被引量:1
  • 3Otten MH, Prince FH, Twilt M, et al. Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis-data from the dutch arthritis and biologicals in children register, 1999-2010[J]. J Rheumatol,2011, 38(10):2258-2263. 被引量:1
  • 4Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis:second revision,Edmonton[J]. J Rheumatol, 2004, 31(2):390-392. 被引量:1
  • 5Shenoi S, Wallace CA.Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis:an evidence.based review[J].Pediatr Drugs,2010,12(6):367-377. 被引量:1
  • 6Boros C, Whitehead B.Juvenile idiopathic arthritis[J].Aust Fam Physician,2010,39(9):630-636. 被引量:1
  • 7Sfikakis PP. The first decade of biologic TNF antagonists in clinical practice:lessons learned, unresolved issues and future directions[J].Curr Dir Autoimmun,2010, 11(1):180-210. 被引量:1
  • 8Alexeeva EI, Valieva SI, Bzarova TM, et al. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis[J]. Clin Rheumatol, 2011, 30(9):1163-72. 被引量:1
  • 9Levalampi T, Honkanen V, Lahdenne P, et al.Effects of infliximab on cytokines,myeloperoxidase,and soluble adhesion molecules in patients with juvenile idiopathic arthritis[J].Scand J Rheumatol, 2007, 36(3):189-193. 被引量:1
  • 10Ruperto N, LoveU DJ,Cuttica R, et al.Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticulareoulse juvenile rheumatoid arthritis:findings from an open-label treatment extension[J].Ann Rheum Dis,2010,69(4):718-722. 被引量:1

共引文献78

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部